Stockscreener 앱 받기
746.54
0.94%
6.97
Regeneron Pharmaceuticals Inc (REGN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
19.01%
4,290.70
|
3,605.40 | 3,884.30 | 3,754.30 | 3,675.60 |
Selling, General, and Administrative
|
2.22%
662.10
|
647.70 | - | - | - |
| Costs And Expenses |
1.17%
2,997.20
|
2,962.50 | 3,004.40 | 2,727.50 | 2,596.10 |
| Operating Income/Loss |
101.20%
1,293.50
|
642.90 | 879.90 | 1,026.80 | 1,079.50 |
| Nonoperating Income/Loss |
24.43%
234.30
|
188.30 | 163.80 | 736.50 | 439.20 |
| Income/Loss From Continuing Operations Before Tax |
83.81%
1,527.80
|
831.20 | 1,043.70 | 1,763.30 | 1,518.70 |
| Income Tax Expense/Benefit |
122.02%
230.90
|
104.00 | 199.10 | 303.30 | 127.10 |
| Net Income/Loss |
78.34%
1,296.90
|
727.20 | 844.60 | 1,460.00 | 1,391.60 |
| Basic Average Shares |
1.15%
102.80
|
104.00 | -0.50 | 103.60 | 105.10 |
| Diluted Average Shares |
1.58%
106.00
|
107.70 | -0.30 | 107.20 | 108.60 |
| Basic Earnings Per Share |
80.54%
12.62
|
6.99 | 8.24 | 14.09 | 13.24 |
| Diluted Earnings Per Share |
81.19%
12.23
|
6.75 | 7.87 | 13.62 | 12.81 |
| Common Stock Dividends |
0.00%
0.94
|
0.94 | 0.88 | 0.88 | 0.88 |
14.21%
자본화:
|
볼륨(24시간):